BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16204057)

  • 21. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion.
    Nakata Y; Kondoh K; Fukushima S; Hashiguchi A; Du W; Hayashi M; Fujimoto J; Hata J; Yamada T
    Exp Hematol; 2008 Jan; 36(1):37-50. PubMed ID: 18037226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
    Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
    Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
    Ching YP; Wong CM; Chan SF; Leung TH; Ng DC; Jin DY; Ng IO
    J Biol Chem; 2003 Mar; 278(12):10824-30. PubMed ID: 12531887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
    Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
    Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
    Martínez-Iglesias O; Garcia-Silva S; Tenbaum SP; Regadera J; Larcher F; Paramio JM; Vennström B; Aranda A
    Cancer Res; 2009 Jan; 69(2):501-9. PubMed ID: 19147563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
    Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
    Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
    Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
    Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway.
    Holeiter G; Heering J; Erlmann P; Schmid S; Jähne R; Olayioye MA
    Cancer Res; 2008 Nov; 68(21):8743-51. PubMed ID: 18974116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GAP-independent functions of DLC1 in metastasis.
    Barras D; Widmann C
    Cancer Metastasis Rev; 2014 Mar; 33(1):87-100. PubMed ID: 24338004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
    Guan M; Tripathi V; Zhou X; Popescu NC
    Cancer Gene Ther; 2008 Jun; 15(6):371-81. PubMed ID: 18369381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of deleted in liver cancer 1 tumor suppressor by protein-protein interactions and phosphorylation.
    Ko FC; Ping Yam JW
    Int J Cancer; 2014 Jul; 135(2):264-9. PubMed ID: 24114040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma.
    Wu HT; Xie CR; Lv J; Qi HQ; Wang F; Zhang S; Fang QL; Wang FQ; Lu YY; Yin ZY
    Lab Invest; 2018 Aug; 98(8):1014-1024. PubMed ID: 29785050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
    Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
    Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
    Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.
    Yuan BZ; Miller MJ; Keck CL; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 1998 May; 58(10):2196-9. PubMed ID: 9605766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.
    Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F
    Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.
    Muehlich S; Hampl V; Khalid S; Singer S; Frank N; Breuhahn K; Gudermann T; Prywes R
    Oncogene; 2012 Aug; 31(35):3913-23. PubMed ID: 22139079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.